** Shares of Australia's EZZ Life Science EZZ.AX rise as much as 5.9% to A$1.715, their highest level since February 9

** Stock hits its biggest intraday pct gain in a week

** The pharma firm says it enters global distribution agreement with Aumake AUK.AX for A$10 million ($7.06 million)

** Co says agreement for distribution and sale of co-developed EZZ-branded products

** Aumake is a retail business based in Australia and New Zealand selling via e-commerce marketplace platforms

** AUK up 50% to A$0.003, hitting its biggest intraday pct gain in two months

** EZZ stock up 20.6% YTD, while AUK remains broadly flat

($1 = 1.4162 Australian dollars)

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))